Beta thalassemia cardiomyopathy

WikiDoc Resources for Beta thalassemia cardiomyopathy
Articles
Most recent articles on Beta thalassemia cardiomyopathy Most cited articles on Beta thalassemia cardiomyopathy Review articles on Beta thalassemia cardiomyopathy Articles on Beta thalassemia cardiomyopathy in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Beta thalassemia cardiomyopathy Images of Beta thalassemia cardiomyopathy Photos of Beta thalassemia cardiomyopathy Podcasts & MP3s on Beta thalassemia cardiomyopathy Videos on Beta thalassemia cardiomyopathy
Evidence Based Medicine
Cochrane Collaboration on Beta thalassemia cardiomyopathy Bandolier on Beta thalassemia cardiomyopathy TRIP on Beta thalassemia cardiomyopathy
Clinical Trials
Ongoing Trials on Beta thalassemia cardiomyopathy at Clinical Trials.gov Trial results on Beta thalassemia cardiomyopathy Clinical Trials on Beta thalassemia cardiomyopathy at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Beta thalassemia cardiomyopathy NICE Guidance on Beta thalassemia cardiomyopathy NHS PRODIGY Guidance FDA on Beta thalassemia cardiomyopathy CDC on Beta thalassemia cardiomyopathy
Books
Books on Beta thalassemia cardiomyopathy
News
Beta thalassemia cardiomyopathy in the news Be alerted to news on Beta thalassemia cardiomyopathy News trends on Beta thalassemia cardiomyopathy
Commentary
Blogs on Beta thalassemia cardiomyopathy
Definitions
Definitions of Beta thalassemia cardiomyopathy
Patient Resources / Community
Patient resources on Beta thalassemia cardiomyopathy Discussion groups on Beta thalassemia cardiomyopathy Patient Handouts on Beta thalassemia cardiomyopathy Directions to Hospitals Treating Beta thalassemia cardiomyopathy Risk calculators and risk factors for Beta thalassemia cardiomyopathy
Healthcare Provider Resources
Symptoms of Beta thalassemia cardiomyopathy Causes & Risk Factors for Beta thalassemia cardiomyopathy Diagnostic studies for Beta thalassemia cardiomyopathy Treatment of Beta thalassemia cardiomyopathy
Continuing Medical Education (CME)
CME Programs on Beta thalassemia cardiomyopathy
International
Beta thalassemia cardiomyopathy en Espanol Beta thalassemia cardiomyopathy en Francais
Business
Beta thalassemia cardiomyopathy in the Marketplace Patents on Beta thalassemia cardiomyopathy
Experimental / Informatics
List of terms related to Beta thalassemia cardiomyopathy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Untreated thalassemia Major eventually leads to death usually by heart failure, therefore birth screening is very important. β-Thalassemia cardiomyopathy takes on two phenotypes:

Dilated phenotype: Left ventricular dilatation and impaired contractility are present

Restrictive phenotype: Restrictive left ventricular filling is present along with pulmonary hypertension, and right heart failure.

The pathophysiology of β-Thalassemia cardiomyopathy is multifactorial, with myocardial iron overload and immunoinflammatory processes being the predominant mechanisms.